BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND ATM, TELO1, 472, ENSG00000149311, TEL1, ATD, ATE, DKFZp781A0353, AT1, Q13315, MGC74674, ATDC, ATC, ATA AND Prognosis
36 results:

  • 1. Comprehensive genomic profiling to identify actionable alterations for breast cancer brain metastases in the Chinese population.
    Lu Q; Wang N; Jiang K; Zhou H; Zhang P; Zhang J; Wang S; Sun P; Xu F
    ESMO Open; 2024 Mar; 9(3):102389. PubMed ID: 38460250
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Co-inhibition of glutaminolysis and one-carbon metabolism promotes ROS accumulation leading to enhancement of chemotherapeutic efficacy in anaplastic thyroid cancer.
    Hwang Y; Yun HJ; Jeong JW; Kim M; Joo S; Lee HK; Chang HS; Kim SM; Fang S
    Cell Death Dis; 2023 Aug; 14(8):515. PubMed ID: 37573361
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Cardiovascular outcomes in patients with cancer during a 5-year follow-up: Results from a French administrative database.
    Boyer J; Deharo P; Angoulvant D; Ivanes F; Ferrara J; Vaillier A; Cautela J; Herbert J; Saint Etienne C; Cuisset T; Thuny F; Fauchier L
    Arch Cardiovasc Dis; 2023 Feb; 116(2):88-97. PubMed ID: 36641244
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Next-Generation Grade and Survival Expression Biomarkers of Human Gliomas Based on Algorithmically Reconstructed Molecular Pathways.
    Zolotovskaia MA; Kovalenko MA; Tkachev VS; Simonov AM; Sorokin MI; Kim E; Kuzmin DV; Karademir-Yilmaz B; Buzdin AA
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806337
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The prognostic value of the preoperative inflammatory index on the survival of glioblastoma patients.
    Shi X; Li H; Xu Y; Nyalali AMK; Li F
    Neurol Sci; 2022 Sep; 43(9):5523-5531. PubMed ID: 35606674
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Integrative analysis of therapy resistance and transcriptomic profiling data in glioblastoma cells identifies sensitization vulnerabilities for combined modality radiochemotherapy.
    Schnöller LE; Albrecht V; Brix N; Nieto AE; Fleischmann DF; Niyazi M; Hess J; Belka C; Unger K; Lauber K; Orth M
    Radiat Oncol; 2022 Apr; 17(1):79. PubMed ID: 35440003
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Mitochondrial DNA sequence variation and risk of glioma.
    Samanic CM; Teer JK; Thompson ZJ; Creed JH; Fridley BL; Burt Nabors L; Williams SL; Egan KM
    Mitochondrion; 2022 Mar; 63():32-36. PubMed ID: 35032707
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Differences in Genomic Alterations Between brain Metastases and Primary Tumors.
    Dono A; Takayasu T; Yan Y; Bundrant BE; Arevalo O; Lopez-Garcia CA; Esquenazi Y; Ballester LY
    Neurosurgery; 2021 Feb; 88(3):592-602. PubMed ID: 33369669
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The Prevalence, Associated Factors for Lung Metastases Development and prognosis in Ovarian Serous cancer Based on SEER Database.
    Cao C; Yang X
    Technol Cancer Res Treat; 2020; 19():1533033820983801. PubMed ID: 33356997
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A risk stratification model for predicting brain metastasis and brain screening benefit in patients with metastatic triple-negative breast cancer.
    Lin M; Jin Y; Jin J; Wang B; Hu X; Zhang J
    Cancer Med; 2020 Nov; 9(22):8540-8551. PubMed ID: 32945619
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Global activation of oncogenic pathways underlies therapy resistance in diffuse midline glioma.
    Georgescu MM; Islam MZ; Li Y; Circu ML; Traylor J; Notarianni CM; Kline CN; Burns DK
    Acta Neuropathol Commun; 2020 Jul; 8(1):111. PubMed ID: 32680567
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Identification of Periostin as a Potential Biomarker in Gliomas by Database Mining.
    Faried A; Hermanto Y; Tjahjono FP; Valentino A; Arifin MZ
    World Neurosurg; 2020 Mar; 135():e137-e163. PubMed ID: 31785437
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Classic ataxia-telangiectasia: the phenotype of long-term survivors.
    van Os NJH; van Deuren M; Weemaes CMR; van Gaalen J; Hijdra H; Taylor AMR; van de Warrenburg BPC; Willemsen MAAP
    J Neurol; 2020 Mar; 267(3):830-837. PubMed ID: 31776720
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. GDF-15 in solid vs non-solid treatment-naïve malignancies.
    Arfsten H; Cho A; Freitag C; Raderer M; Goliasch G; Bartko PE; Wurm R; Strunk G; Gisslinger H; Marosi C; Kornek G; Zielinski C; Hülsmann M; Pavo N
    Eur J Clin Invest; 2019 Nov; 49(11):e13168. PubMed ID: 31463975
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. prognosis of Six-Month Glasgow Outcome Scale in Severe Traumatic brain Injury Using Hospital Admission Characteristics, Injury Severity Characteristics, and Physiological Monitoring during the First Day Post-Injury.
    Rubin ML; Yamal JM; Chan W; Robertson CS
    J Neurotrauma; 2019 Aug; 36(16):2417-2422. PubMed ID: 30860434
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The SIAH1-HIPK2-p53ser46 Damage Response Pathway is Involved in Temozolomide-Induced Glioblastoma Cell Death.
    He Y; Roos WP; Wu Q; Hofmann TG; Kaina B
    Mol Cancer Res; 2019 May; 17(5):1129-1141. PubMed ID: 30796178
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. ataxia-Telangiectasia-Mutated Protein Expression as a Prognostic Marker in Adenoid Cystic Carcinoma of the Salivary Glands.
    Bazarsad S; Kim JY; Zhang X; Kim KY; Lee DY; Ryu MH; Kim J
    Yonsei Med J; 2018 Aug; 59(6):717-726. PubMed ID: 29978608
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Induced Telomere Damage to Treat Telomerase Expressing Therapy-Resistant Pediatric brain Tumors.
    Sengupta S; Sobo M; Lee K; Senthil Kumar S; White AR; Mender I; Fuller C; Chow LML; Fouladi M; Shay JW; Drissi R
    Mol Cancer Ther; 2018 Jul; 17(7):1504-1514. PubMed ID: 29654065
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Meta-analysis of the prognostic value of the neutrophil-to-lymphocyte ratio in oral squamous cell carcinoma.
    Wang Y; Wang P; Andrukhov O; Wang T; Song S; Yan C; Zhang F
    J Oral Pathol Med; 2018 Apr; 47(4):353-358. PubMed ID: 29406591
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Loss of ATRX suppresses atm dependent DNA damage repair by modulating H3K9me3 to enhance temozolomide sensitivity in glioma.
    Han B; Cai J; Gao W; Meng X; Gao F; Wu P; Duan C; Wang R; Dinislam M; Lin L; Kang C; Jiang C
    Cancer Lett; 2018 Apr; 419():280-290. PubMed ID: 29378238
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.